| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $387.1M | — | +39.0% |
| Cost of Revenue | $75.3M | — | +24.5% |
| Gross Profit | $311.8M | — | +43.0% |
| R&D Expense | $114.3M | — | +39.8% |
| SG&A Expense | $57.0M | — | -3.9% |
| Operating Income | -$52.6M | — | +43.5% |
| Interest Expense | $1.1M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $429.4M | +12.9% | +51.2% |
| Accounts Receivable | $199.3M | -22.4% | +20.4% |
| Inventory | $7.0M | +24.1% | +53.6% |
| Current Assets | $2.22B | +0.0% | +99.1% |
| Total Assets | $2.77B | +0.1% | +87.7% |
| Current Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $81.7M | — | +106.0% |
| Capital Expenditures | $4.3M | — | +50.1% |
| Investing Cash Flow | -$36.2M | — | -205.9% |
| Financing Cash Flow | $17.2M | — | +12.2% |
| Free Cash Flow | $77.4M | — | +110.3% |
| -89.1% |
| Pre-tax Income | -$37.2M | — | +63.1% |
| Income Tax | $4.6M | — | +264.0% |
| Net Income | -$41.9M | — | +59.0% |
| EPS (Basic) | -$0.21 | — | +60.4% |
| EPS (Diluted) | -$0.21 | — | +60.4% |
| $1.28B |
| -2.6% |
| +33.2% |
| Total Liabilities | $3.25B | -1.1% | +60.0% |
| Stockholders' Equity | -$481.3M | +7.4% | +13.5% |